Kendra Bjoraker

826 total citations
18 papers, 536 citations indexed

About

Kendra Bjoraker is a scholar working on Physiology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Kendra Bjoraker has authored 18 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 6 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Kendra Bjoraker's work include Lysosomal Storage Disorders Research (10 papers), Metabolism and Genetic Disorders (6 papers) and Family and Disability Support Research (3 papers). Kendra Bjoraker is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Metabolism and Genetic Disorders (6 papers) and Family and Disability Support Research (3 papers). Kendra Bjoraker collaborates with scholars based in United States, Canada and Australia. Kendra Bjoraker's co-authors include Elsa Shapiro, Paul J. Orchard, Jakub Tolar, Lawrence Charnas, C B Whitley, William Krivit, Kathleen Delaney, Charles Peters, Gülin Öz and In‐Young Choi and has published in prestigious journals such as Neurology, Annals of Neurology and The Journal of Pediatrics.

In The Last Decade

Kendra Bjoraker

18 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kendra Bjoraker United States 11 315 158 133 90 88 18 536
Esmée Oussoren Netherlands 15 383 1.2× 245 1.6× 89 0.7× 169 1.9× 166 1.9× 32 768
Ana Marcão Portugal 12 402 1.3× 188 1.2× 159 1.2× 169 1.9× 160 1.8× 22 616
Giulia Polo Italy 17 589 1.9× 248 1.6× 228 1.7× 200 2.2× 132 1.5× 29 871
F. A. Beemer Netherlands 12 293 0.9× 232 1.5× 106 0.8× 101 1.1× 248 2.8× 21 714
Alexander Broomfield United Kingdom 14 358 1.1× 205 1.3× 140 1.1× 124 1.4× 137 1.6× 54 613
María Josep Coll Spain 19 703 2.2× 370 2.3× 158 1.2× 228 2.5× 180 2.0× 37 1.1k
Clare Beesley United Kingdom 17 607 1.9× 288 1.8× 189 1.4× 262 2.9× 241 2.7× 29 980
Orna Staretz‐Chacham Israel 14 165 0.5× 227 1.4× 83 0.6× 90 1.0× 61 0.7× 38 617
Hélène Ogier France 13 292 0.9× 443 2.8× 415 3.1× 109 1.2× 113 1.3× 16 877
Dimitar Gavrilov United States 15 345 1.1× 403 2.6× 437 3.3× 102 1.1× 152 1.7× 35 901

Countries citing papers authored by Kendra Bjoraker

Since Specialization
Citations

This map shows the geographic impact of Kendra Bjoraker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra Bjoraker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra Bjoraker more than expected).

Fields of papers citing papers by Kendra Bjoraker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra Bjoraker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra Bjoraker. The network helps show where Kendra Bjoraker may publish in the future.

Co-authorship network of co-authors of Kendra Bjoraker

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra Bjoraker. A scholar is included among the top collaborators of Kendra Bjoraker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra Bjoraker. Kendra Bjoraker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bjoraker, Kendra, Kristin Lindstrom, Markey McNutt, et al.. (2023). Best practice recommendations for the management of anxiety during the pegvaliase journey. Molecular Genetics and Metabolism. 141(1). 107737–107737. 3 indexed citations
2.
Bjoraker, Kendra, et al.. (2021). Serendipitous discovery of phenylketonuria in Iraq – How to identify and treat?. Molecular Genetics and Metabolism Reports. 27. 100737–100737. 2 indexed citations
3.
4.
Bjoraker, Kendra, Michael A. Swanson, Curtis R. Coughlin, et al.. (2016). Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia. The Journal of Pediatrics. 170. 234–239. 47 indexed citations
5.
Kunin‐Batson, Alicia, Elsa Shapiro, Kyle Rudser, et al.. (2015). Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation. JIMD Reports. 29. 95–102. 30 indexed citations
6.
Swanson, Michael A., Curtis R. Coughlin, Gunter Scharer, et al.. (2015). Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Annals of Neurology. 78(4). 606–618. 54 indexed citations
7.
Shapiro, Elsa, Özkan Güler, Kyle Rudser, et al.. (2012). An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT). Molecular Genetics and Metabolism. 107(1-2). 116–121. 31 indexed citations
8.
Orchard, Paul J., Carlos Milla, Elizabeth Braunlin, et al.. (2009). Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplantation. 45(7). 1239–1246. 27 indexed citations
9.
Shapiro, Elsa, Kendra Bjoraker, Kathleen Delaney, et al.. (2009). 130. Neuropsychological outcomes in Hurler syndrome: 7–20 years post-hematopoietic stem cell transplantion. Molecular Genetics and Metabolism. 96(2). S40–S41. 2 indexed citations
10.
Tolar, Jakub, Anna Petryk, Khalid Khan, et al.. (2008). Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplantation. 43(1). 21–27. 53 indexed citations
11.
Shapiro, Elsa, et al.. (2008). 89. Neuropsychological function and neuroimaging in severe and attenuated mucopolysaccharidosis. Molecular Genetics and Metabolism. 93(2). 37–37. 2 indexed citations
12.
Tolar, Jakub, Kendra Bjoraker, C B Whitley, et al.. (2007). Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplantation. 41(6). 531–535. 99 indexed citations
13.
Khanna, Gaurav, Ann E. Van Heest, Julie Agel, et al.. (2007). Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplantation. 39(6). 331–334. 34 indexed citations
14.
Tolar, Jakub, Paul J. Orchard, Kendra Bjoraker, et al.. (2007). N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplantation. 39(4). 211–215. 40 indexed citations
15.
Shapiro, Elsa, et al.. (2007). 31 Hippocampal functions in MPS I: A pilot study of memory encoding and visual spatial function. Molecular Genetics and Metabolism. 92(4). 18–19. 1 indexed citations
16.
Charnas, Lawrence, Elizabeth Braunlin, Kendra Bjoraker, et al.. (2007). 99 Treatment of multiple sulfatase deficiency with recombinant human arylsulfatase B. Molecular Genetics and Metabolism. 92(4). 31–31. 1 indexed citations
17.
Bjoraker, Kendra, Kathleen Delaney, Charles Peters, William Krivit, & Elsa Shapiro. (2006). Long-term Outcomes of Adaptive Functions for Children with Mucopolysaccharidosis I (Hurler Syndrome) Treated with Hematopoietic Stem Cell Transplantation. Journal of Developmental & Behavioral Pediatrics. 27(4). 290–296. 46 indexed citations
18.
Öz, Gülin, Lawrence Charnas, In‐Young Choi, et al.. (2005). Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology. 64(3). 434–441. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esmée Oussoren Breakdown of academic impact, for papers by Ana Marcão Breakdown of academic impact, for papers by Giulia Polo Breakdown of academic impact, for papers by F. A. Beemer Breakdown of academic impact, for papers by Alexander Broomfield Breakdown of academic impact, for papers by María Josep Coll Breakdown of academic impact, for papers by Clare Beesley Breakdown of academic impact, for papers by Orna Staretz‐Chacham Breakdown of academic impact, for papers by Hélène Ogier Breakdown of academic impact, for papers by Dimitar Gavrilov
Rankless by CCL
2026